Malin Corporation Plc
MLC | IR
Overview
Corporate Details
- ISIN(s):
- IE00BVGC3741
- LEI:
- 635400JG4YSDU5U1YU17
- Country:
- Ireland
- Address:
- The Lennox Building, D02 FK02 Dublin
- Website:
- http://malinplc.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Malin invests in and supports highly innovative life sciences companies developing exceptional science and technology to deliver transformative outcomes for patients and create significant value for shareholders. Our purpose is to create shareholder value through the application of long-term capital and strategic support to our investee companies to enable them to reach their value potential. Vision: To deliver significant returns for our shareholders and transformative outcomes for patients by investing in and supporting highly innovative life sciences companies
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-05-28 11:45 |
Director's Dealing
Director/PDMR Shareholding
|
English | 14.7 KB | |
| 2025-03-28 18:00 |
Director's Dealing
Director/PDMR Shareholding
|
English | 37.7 KB | |
| 2025-03-13 13:45 |
Post-Annual General Meeting Information
Result of AGM & EGM
|
English | 35.3 KB | |
| 2025-02-19 08:00 |
Annual Report
2024 Full Year Results & Notice of AGM
|
English | 28.7 KB | |
| 2025-02-19 08:00 |
Post-Annual General Meeting Information
Proposed Tender Offer
|
English | 52.7 KB | |
| 2025-02-05 08:00 |
Share Issue/Capital Change
Update on Return of Capital to Shareholders
|
English | 11.6 KB | |
| 2025-01-08 08:30 |
M&A Activity
Update re Poseida Transaction
|
English | 8.7 KB | |
| 2024-11-26 08:00 |
M&A Activity
Poseida to be Acquired and Update on Tender Offer
|
English | 13.2 KB | |
| 2024-11-12 08:00 |
Share Issue/Capital Change
Proposed Tender Offer
|
English | 54.2 KB | |
| 2024-11-04 08:00 |
Share Issue/Capital Change
Block listing Interim Review
|
English | 13.4 KB | |
| 2024-09-26 16:45 |
Post-Annual General Meeting Information
Result of EGM
|
English | 10.8 KB | |
| 2024-08-27 08:00 |
Earnings Release
2024 Interim Report
|
English | 25.2 KB | |
| 2024-08-20 08:00 |
Report Publication Announcement
Notice of 2024 Interim Results
|
English | 9.5 KB | |
| 2024-07-23 17:30 |
Earnings Release
Business Updates
|
English | 31.3 KB | |
| 2024-07-10 18:30 |
Major Shareholding Notification
Holding(s) in Company
|
English | 9.4 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
ABIVAX | France | ABVX | |
|
Addex Therapeutics Ltd | Switzerland | ADXN | |
|
AegirBio AB | Sweden | AEGIR | |
|
AGRONOMICS LIMITED | Isle of Man | ANIC | |
|
AIREA PLC | United Kingdom | AIEA | |
|
Alkaloid AD | North Macedonia | ALK | |
| Alma Yesodot Ltd. | Israel | KVSR | ||
|
Amphastar Pharmaceuticals Inc. | United States of America | AMPH | |
| Ananda Pharma Plc | United Kingdom | N/A | ||
|
AnGes, Inc. | Japan | 4563 |